blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1569656

EP1569656 - PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.01.2011
Database last updated on 03.10.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Innate Pharma
Immeuble Grand Pré, 121, ancien Chemin de Cassis
13009 Marseille / FR
[2010/09]
Former [2005/36]For all designated states
Innate Pharma
Immeuble Grand Pré, 121, ancien chemin de Cassis
13009 Marseille / FR
Inventor(s)01 / ROMAGNE, François
Bat. A3, Les Hauts de Fontsainte
F-13600 La Ciotat / FR
02 / SICARD, Hélène
19 Beauvallon Centre
F-13009 Marseille / FR
03 / TIOLLIER, Jérôme
17 rue Bienvenu
F-13008 Marseille / FR
04 / BELMANT, Christian
36 Impasse du Hameau de la Tour
83140 Six-Fours-Les-Plages / FR
 [2005/36]
Representative(s)Gallois, Valérie, et al
Cabinet BECKER & ASSOCIES
25, rue Louis Le Grand
75002 Paris / FR
[N/P]
Former [2005/36]Gallois, Valérie, et al
Cabinet BECKER & ASSOCIES 25, rue Louis Le Grand
75002 Paris / FR
Application number, filing date03768074.102.12.2003
[2005/36]
WO2003IB06375
Priority number, dateEP2002029296302.12.2002         Original published format: EP 02292963
[2005/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004050096
Date:17.06.2004
Language:EN
[2004/25]
Type: A2 Application without search report 
No.:EP1569656
Date:07.09.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 17.06.2004 takes the place of the publication of the European patent application.
[2005/36]
Type: B1 Patent specification 
No.:EP1569656
Date:03.03.2010
Language:EN
[2010/09]
Search report(s)International search report - published on:EP16.09.2004
ClassificationIPC:A61K31/66, A61K45/06, A61P35/00, A61P37/00, A61P35/04
[2005/36]
CPC:
A61K45/06 (EP,US); A61K38/2013 (EP,US); A61P31/00 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/04 (EP); A61P37/08 (EP) (-)
C-Set:
A61K38/2013, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/36]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PHOSPHOANTIGEN ENTHALTENE ZUSAMMENSETZUNGEN ZUR REGULIERUNG VON IMMUNEREAKTIONEN[2009/42]
English:PHOSPHOANTIGENS FOR REGULATING AN IMMUNE RESPONSE[2005/36]
French:COMPOSITIONS ET TECHNIQUES DE REGULATION DE REPONSE IMMUNE CHEZ UN PATIENT[2005/36]
Former [2005/36]PHOSPHOANTIGEN ENTHALTENE ZUSAMMENSETZUNGEN ZUR REGULIERING VON IMMUNEREAKTIONEN
Entry into regional phase02.06.2005National basic fee paid 
02.06.2005Designation fee(s) paid 
02.06.2005Examination fee paid 
Examination procedure02.06.2005Amendment by applicant (claims and/or description)
02.06.2005Examination requested  [2005/36]
11.05.2007Despatch of a communication from the examining division (Time limit: M06)
20.09.2007Reply to a communication from the examining division
17.09.2009Communication of intention to grant the patent
14.01.2010Fee for grant paid
14.01.2010Fee for publishing/printing paid
Opposition(s)06.12.2010No opposition filed within time limit [2011/06]
Fees paidRenewal fee
02.06.2005Renewal fee patent year 03
05.12.2006Renewal fee patent year 04
10.12.2007Renewal fee patent year 05
13.11.2008Renewal fee patent year 06
17.11.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
TR03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
HU04.09.2010
GB02.12.2010
IE02.12.2010
LU02.12.2010
[2012/47]
Former [2012/44]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
HU04.09.2010
GB02.12.2010
IE02.12.2010
LU02.12.2010
Former [2012/42]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
HU04.09.2010
GB02.12.2010
IE02.12.2010
Former [2012/01]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
GB02.12.2010
IE02.12.2010
Former [2011/47]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
IE02.12.2010
Former [2011/15]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
IT03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
Former [2011/08]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
PT05.07.2010
Former [2011/07]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
DK03.03.2010
EE03.03.2010
FI03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
Former [2010/51]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
EE03.03.2010
FI03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
BG03.06.2010
GR04.06.2010
ES14.06.2010
Former [2010/49]AT03.03.2010
BE03.03.2010
CY03.03.2010
CZ03.03.2010
EE03.03.2010
FI03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
SK03.03.2010
GR04.06.2010
ES14.06.2010
Former [2010/48]AT03.03.2010
BE03.03.2010
CY03.03.2010
EE03.03.2010
FI03.03.2010
RO03.03.2010
SE03.03.2010
SI03.03.2010
GR04.06.2010
ES14.06.2010
Former [2010/46]AT03.03.2010
FI03.03.2010
SI03.03.2010
GR04.06.2010
ES14.06.2010
Former [2010/38]AT03.03.2010
FI03.03.2010
SI03.03.2010
Former [2010/37]AT03.03.2010
SI03.03.2010
Former [2010/36]SI03.03.2010
Cited inInternational search[XD]WO0012519  (INST NAT SANTE RECH MED [FR], et al) [XD] 1,2,26,27,30,73 * page 21, line 19 - line 23 *;
 [DX]WO0059916  (INST NAT SANTE RECH MED [FR], et al) [DX] 49,57-72,74-77 * page 17, line 21 - line 25; example 14; tables I,II *;
 [X]US2002142996  (OKUNO TETSUJI [JP], et al) [X] 1-8,16-21 * abstract * * paragraphs [0009] , [0050] , [ 0052] *;
 [DXP]WO03009855  (JOMAA PHARMAKA GMBH [DE], et al) [DXP] 1,2,26,40-42,50,51,78 * p. 10, compounds 15 (=CHDMAPP) and 17 (=HDMAPP) *; page 13, line 8 - line 31; claims 1-42 *;
 [DX]  - KUNZMANN VOLKER ET AL, "Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma", BLOOD, &, (20000715), vol. 96, no. 2, ISSN 0006-4971, pages 384 - 392, XP002276947 [DX] 1,16-20,25,26,40,73 * abstract *
 [PX]  - WILHELM MARTIN ET AL, "gammadelta T cells for immune therapy of patients with lymphoid malignancies.", BLOOD, &, (20030701), vol. 102, no. 1, ISSN 0006-4971, pages 200 - 206, XP002276948 [PX] 1,2,57-65,67,68,71-77 * abstract *

DOI:   http://dx.doi.org/10.1182/blood-2002-12-3665
 [PX]  - PROMT, (20031215), Database accession no. 2003:627750, URL: STN, XP002276950 [PX] 1,2,16-28,49,73 * abstract *
 [X]  - PHIN, (20020308), Database accession no. :2002:6085, URL: STN, XP002276951 [X] 1,2,16-28,49,73 * abstract *
    [ ] - ANONYMOUS, "Innate gets Euros2 million loan from French agency", SCRIP, (20020308), no. 2727, page 7
 [X]  - "Innate Pharma exceeds objectives in obtaining funding for first clinical trials.", CBNB, Database accession no. 19(9):12851, URL: STN, XP002276952 [X] 1,2,16-28,49,73 * abstract *
 [T]  - MONTALVETTI ANDREA ET AL, "Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei: In vitro RNA interference and in vivo inhibition studies", J. BIOL. CHEM.; JOURNAL OF BIOLOGICAL CHEMISTRY MAY 9 2003, (20030509), vol. 278, no. 19, pages 17075 - 17083, XP002276949 [T] 1-79 *Fig. 1, Formula 10 phosphostim *

DOI:   http://dx.doi.org/10.1074/jbc.M210467200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.